Health Technology · Pharmaceuticals: Major · NSE: SPARC · data 2026-10-09

Sun Pharma Advanced Research Co. Ltd.

Health check: Strong (8.9/10 on quality, valuation vs sector, growth and momentum).

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹185.6

Market cap

₹6,098 cr

P/E

3.8

P/B

—

ROE

276.9%

ROCE

232.1%

Debt / equity

0.42

Dividend yield

0.00%

1-year return

44.9%

52-week high

₹289

52-week low

₹108

Operating margin

84.2%

Growth

Revenue (last 12 months)	₹1,909 cr
Net profit (last 12 months)	₹1,584 cr
Sales growth, 3 years (yearly)	98.9%
Profit growth, 3 years (yearly)	—

Similar companies

Supriya Lifescience Limited (SUPRIYA) · Sanofi India Limited (SANOFI) · Innova Captab Limited (INNOVACAP) · Senores Pharmaceuticals Ltd. (SENORES) · Orchid Pharma Limited (ORCHPHARMA)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open SPARC in NSE Scanner →